These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 18426498)

  • 21. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocannabinoids, feeding and suckling--from our perspective.
    Mechoulam R; Berry EM; Avraham Y; Di Marzo V; Fride E
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S24-8. PubMed ID: 16570101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal hormones regulating appetite.
    Chaudhri O; Small C; Bloom S
    Philos Trans R Soc Lond B Biol Sci; 2006 Jul; 361(1471):1187-209. PubMed ID: 16815798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus.
    Soria-Gómez E; Matias I; Rueda-Orozco PE; Cisneros M; Petrosino S; Navarro L; Di Marzo V; Prospéro-García O
    Br J Pharmacol; 2007 Aug; 151(7):1109-16. PubMed ID: 17549045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward.
    Mahler SV; Smith KS; Berridge KC
    Neuropsychopharmacology; 2007 Nov; 32(11):2267-78. PubMed ID: 17406653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects.
    Hellström PM; Geliebter A; Näslund E; Schmidt PT; Yahav EK; Hashim SA; Yeomans MR
    Br J Nutr; 2004 Aug; 92 Suppl 1():S47-57. PubMed ID: 15384323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine and autonomic control of metabolic functions: recent advances.
    Müller EE
    Eat Weight Disord; 2008 Sep; 13(3):e61-6. PubMed ID: 19011366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An anorexic lipid mediator regulated by feeding.
    Rodríguez de Fonseca F; Navarro M; Gómez R; Escuredo L; Nava F; Fu J; Murillo-Rodríguez E; Giuffrida A; LoVerme J; Gaetani S; Kathuria S; Gall C; Piomelli D
    Nature; 2001 Nov; 414(6860):209-12. PubMed ID: 11700558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute activation of cannabinoid receptors by anandamide reduces gastrointestinal motility and improves postprandial glycemia in mice.
    Troy-Fioramonti S; Demizieux L; Gresti J; Muller T; Vergès B; Degrace P
    Diabetes; 2015 Mar; 64(3):808-18. PubMed ID: 25281429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oleoylethanolamide and human neural responses to food stimuli in obesity.
    Grosshans M; Schwarz E; Bumb JM; Schaefer C; Rohleder C; Vollmert C; Vollstädt-Klein S; Tost H; Meyer-Lindenberg A; Kiefer F; Leweke FM
    JAMA Psychiatry; 2014 Nov; 71(11):1254-61. PubMed ID: 25229205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents.
    Igarashi M; DiPatrizio NV; Narayanaswami V; Piomelli D
    Biochim Biophys Acta; 2015 Sep; 1851(9):1218-26. PubMed ID: 26024927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour.
    Sihag J; Jones PJH
    Obes Rev; 2018 Feb; 19(2):178-197. PubMed ID: 29124885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of subthalamic neuron activity by endocannabinoids.
    Morera-Herreras T; Ruiz-Ortega JA; Taupignon A; Baufreton J; Manuel I; Rodriguez-Puertas R; Ugedo L
    Synapse; 2010 Sep; 64(9):682-98. PubMed ID: 20336631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anandamide: an update.
    Smita K; Sushil Kumar V; Premendran JS
    Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.
    Hansen HS
    Exp Neurol; 2010 Jul; 224(1):48-55. PubMed ID: 20353771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
    Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
    Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.
    Kirkham TC; Williams CM; Fezza F; Di Marzo V
    Br J Pharmacol; 2002 Jun; 136(4):550-7. PubMed ID: 12055133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Appetite regulation and energy balance.
    Erlanson-Albertsson C
    Acta Paediatr Suppl; 2005 Jun; 94(448):40-1. PubMed ID: 16175806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of fatty acids and their endocannabinoid-like derivatives in the molecular regulation of appetite.
    Witkamp RF
    Mol Aspects Med; 2018 Dec; 64():45-67. PubMed ID: 29325757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain-gut axis and its role in the control of food intake.
    Konturek SJ; Konturek JW; Pawlik T; Brzozowski T
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):137-54. PubMed ID: 15082874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.